Banque Transatlantique Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$79.2M |
| 2 |
CRH
CRH
|
+$66.2M |
| 3 |
Eaton
ETN
|
+$36.3M |
| 4 |
TSMC
TSM
|
+$35.4M |
| 5 |
Broadcom
AVGO
|
+$35.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$33M |
| 2 |
Eli Lilly
LLY
|
+$23.7M |
| 3 |
Home Depot
HD
|
+$19M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$18.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.72% |
| 2 | Consumer Discretionary | 12.97% |
| 3 | Communication Services | 10.13% |
| 4 | Healthcare | 8.84% |
| 5 | Consumer Staples | 8.83% |
Similar funds
Banque Transatlantique's Q1 2026 Portfolio in Review
As of Q1 2026, Banque Transatlantique held 452 positions worth $4.17B, up 1.1% from $4.13B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Banque Transatlantique deployed $360M of net new capital in Q1 2026, opening 193 new positions and adding to 101 existing holdings. Its largest new stake was HCA Healthcare: 24,502 shares worth $11.7M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Boston Scientific, an estimated $33M trimmed.
- Banque Transatlantique's largest Q1 2026 buy was HCA Healthcare: 24,502 shares worth $11.7M.
- Banque Transatlantique added most to Trane Technologies in Q1 2026, an estimated $79.2M increase.
- Banque Transatlantique's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $33M.
- Banque Transatlantique fully exited GRAIL Inc in Q1 2026, selling an estimated $1.97M.
- Banque Transatlantique's ten largest holdings make up 59% of its $4.17B portfolio in Q1 2026.
- Banque Transatlantique opened 193 new positions and closed 10 in Q1 2026.
- Banque Transatlantique's portfolio value rose 1.1% quarter-over-quarter to $4.17B.
Based on Banque Transatlantique's 13F filing for Q1 2026, filed 13 May 2026.